Cargando…
Intravenous dexmedetomidine as an adjunct to subarachnoid block: A simple effective method of better perioperative efficacy
BACKGROUND AND AIM: Dexmedetomidine (D) is a α2 agonist, has anesthetic and analgesic-sparing property. The objective of this study was to evaluate the effect of intravenous (I.V.) dexmedetomidine on the duration of sensory and motor block, postoperative analgesia, the level of sedation and side eff...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520593/ https://www.ncbi.nlm.nih.gov/pubmed/28781446 http://dx.doi.org/10.4103/joacp.JOACP_367_15 |
_version_ | 1783251839751290880 |
---|---|
author | Kumari, Rekha Kumar, Anil Kumar, Sushil Singh, Rakesh |
author_facet | Kumari, Rekha Kumar, Anil Kumar, Sushil Singh, Rakesh |
author_sort | Kumari, Rekha |
collection | PubMed |
description | BACKGROUND AND AIM: Dexmedetomidine (D) is a α2 agonist, has anesthetic and analgesic-sparing property. The objective of this study was to evaluate the effect of intravenous (I.V.) dexmedetomidine on the duration of sensory and motor block, postoperative analgesia, the level of sedation and side effect. MATERIAL AND METHODS: Sixty patients were randomly divided into two groups of thirty each. Group D received dexmedetomidine infusion @1 mcg/kg over 10 min and then @ 0.6 mcg/kg/h for rest of duration during surgery, Group C (control) received a similar volume of normal saline infusion before spinal anesthesia with 3 ml of bupivacaine 0.5%. Time of onset and regression time for sensory and motor blockade, the maximum upper level of sensory blockade, duration of postoperative analgesia, Ramsay sedation score and hemodynamic parameters were recorded. Intraoperative bradycardia and atropine requirement along with other side effect were also recorded. RESULTS: The duration of sensorimotor block was significantly longer in D Group (341.7 ± 20.8 min for sensory block and 278.0 ± 11.0 min for motor block) as compared to control group (329.5 ± 22.1 min for sensory block and 250.0 ± 14.8 min for motor block), which was statistically significant (P < 0.05). The mean time for two dermatomal regression of sensory blockade was significantly prolonged in dexmedetomidine group (115.5 ± 8.7 min) compared to control group (95.8 ± 11.4) (P < 0.001). Intraoperative Ramsay sedation scores were significantly higher in D Group (mean - 3.4 ± 0.7, range – 2–4) as compared to C Group (mean - 2.9 ± 0.3, range – 2–4) (P < 0.001). 26.7% (8/30) cases had bradycardia that required atropine as compared to control group (2/30), and none of the patients in the dexmedetomidine group had postoperative shivering as compared to 10% in control group (P = 0.056). Statistical analysis was performed with statistical package for the social science version-20 using analysis of variance/Chi-square test/unpaired t-test, and P < 0.05 was considered statistically significant. CONCLUSION: I.V. dexmedetomidine significantly prolongs the duration of sensory and motor block of bupivacaine spinal anesthesia. Dexmedetomidine provides an excellent sedation during surgery. |
format | Online Article Text |
id | pubmed-5520593 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-55205932017-08-04 Intravenous dexmedetomidine as an adjunct to subarachnoid block: A simple effective method of better perioperative efficacy Kumari, Rekha Kumar, Anil Kumar, Sushil Singh, Rakesh J Anaesthesiol Clin Pharmacol Original Article BACKGROUND AND AIM: Dexmedetomidine (D) is a α2 agonist, has anesthetic and analgesic-sparing property. The objective of this study was to evaluate the effect of intravenous (I.V.) dexmedetomidine on the duration of sensory and motor block, postoperative analgesia, the level of sedation and side effect. MATERIAL AND METHODS: Sixty patients were randomly divided into two groups of thirty each. Group D received dexmedetomidine infusion @1 mcg/kg over 10 min and then @ 0.6 mcg/kg/h for rest of duration during surgery, Group C (control) received a similar volume of normal saline infusion before spinal anesthesia with 3 ml of bupivacaine 0.5%. Time of onset and regression time for sensory and motor blockade, the maximum upper level of sensory blockade, duration of postoperative analgesia, Ramsay sedation score and hemodynamic parameters were recorded. Intraoperative bradycardia and atropine requirement along with other side effect were also recorded. RESULTS: The duration of sensorimotor block was significantly longer in D Group (341.7 ± 20.8 min for sensory block and 278.0 ± 11.0 min for motor block) as compared to control group (329.5 ± 22.1 min for sensory block and 250.0 ± 14.8 min for motor block), which was statistically significant (P < 0.05). The mean time for two dermatomal regression of sensory blockade was significantly prolonged in dexmedetomidine group (115.5 ± 8.7 min) compared to control group (95.8 ± 11.4) (P < 0.001). Intraoperative Ramsay sedation scores were significantly higher in D Group (mean - 3.4 ± 0.7, range – 2–4) as compared to C Group (mean - 2.9 ± 0.3, range – 2–4) (P < 0.001). 26.7% (8/30) cases had bradycardia that required atropine as compared to control group (2/30), and none of the patients in the dexmedetomidine group had postoperative shivering as compared to 10% in control group (P = 0.056). Statistical analysis was performed with statistical package for the social science version-20 using analysis of variance/Chi-square test/unpaired t-test, and P < 0.05 was considered statistically significant. CONCLUSION: I.V. dexmedetomidine significantly prolongs the duration of sensory and motor block of bupivacaine spinal anesthesia. Dexmedetomidine provides an excellent sedation during surgery. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5520593/ /pubmed/28781446 http://dx.doi.org/10.4103/joacp.JOACP_367_15 Text en Copyright: © 2017 Journal of Anaesthesiology Clinical Pharmacology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Kumari, Rekha Kumar, Anil Kumar, Sushil Singh, Rakesh Intravenous dexmedetomidine as an adjunct to subarachnoid block: A simple effective method of better perioperative efficacy |
title | Intravenous dexmedetomidine as an adjunct to subarachnoid block: A simple effective method of better perioperative efficacy |
title_full | Intravenous dexmedetomidine as an adjunct to subarachnoid block: A simple effective method of better perioperative efficacy |
title_fullStr | Intravenous dexmedetomidine as an adjunct to subarachnoid block: A simple effective method of better perioperative efficacy |
title_full_unstemmed | Intravenous dexmedetomidine as an adjunct to subarachnoid block: A simple effective method of better perioperative efficacy |
title_short | Intravenous dexmedetomidine as an adjunct to subarachnoid block: A simple effective method of better perioperative efficacy |
title_sort | intravenous dexmedetomidine as an adjunct to subarachnoid block: a simple effective method of better perioperative efficacy |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520593/ https://www.ncbi.nlm.nih.gov/pubmed/28781446 http://dx.doi.org/10.4103/joacp.JOACP_367_15 |
work_keys_str_mv | AT kumarirekha intravenousdexmedetomidineasanadjuncttosubarachnoidblockasimpleeffectivemethodofbetterperioperativeefficacy AT kumaranil intravenousdexmedetomidineasanadjuncttosubarachnoidblockasimpleeffectivemethodofbetterperioperativeefficacy AT kumarsushil intravenousdexmedetomidineasanadjuncttosubarachnoidblockasimpleeffectivemethodofbetterperioperativeefficacy AT singhrakesh intravenousdexmedetomidineasanadjuncttosubarachnoidblockasimpleeffectivemethodofbetterperioperativeefficacy |